ANI Pharmaceuticals Inc (NAS:ANIP)
$ 61.43 -2.34 (-3.67%) Market Cap: 1.29 Bil Enterprise Value: 1.36 Bil PE Ratio: 38.88 PB Ratio: 2.85 GF Score: 85/100

ANI Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 05, 2020 / 02:00PM GMT
Release Date Price: $32.17 (+3.74%)
Operator

Welcome to the 2020 Annual Meeting for ANI Pharmaceuticals, Inc. Our host for today's call is Robert Brown. (Operator Instructions). I will now like to turn the call over to your host. Mr. Brown, you may begin.

Robert E. Brown
ANI Pharmaceuticals, Inc. - Independent Chairman of the Board

Thank you. Good morning, everyone, and welcome to ANI's 2020 Virtual Annual Meeting of Stockholders. I am Robert E. Brown, Jr., Chairman of ANI's Board of Directors. Joining me today are Patrick D. Walsh, Interim CEO and Director; Thomas Haughey, Director; David B. Nash, MD, MBA, Director; Stephen P. Carey, Vice President Finance and CFO; Robert W. Schrepfer, Senior Vice President, New Business Development and Specialty Sales; Brian Lee, representing our outside counsel, Dentons US LLP; and Joseph DiFalco, representing our independent auditors, EisnerAmper LLP.

As you all know, Patrick Walsh is our interim CEO, while our search -- our executive search firm is conducting the search for a President and CEO. Pat, would you like to offer a few introductory remarks?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot